How to treat the treatment system

Heroin Addiction and Related Clinical Problems

Volumn 16, Issue 1, 2014, Pages 45-48

  Reisinger, Marc ^a  

^a Europ Opiate Addict Treatm Assoc   (Belgium)

Author keywords

Critics; Treatment issues; Treatment system

Indexed keywords

BUPRENORPHINE; OPIATE AGONIST;

ADDICTION; ARTICLE; AWARENESS; BELGIUM; CHRONIC DISEASE; DRUG DEPENDENCE; DRUG OVERDOSE; FRANCE; GENERAL PRACTITIONER; HEALTH CARE ACCESS; HEALTH CARE SYSTEM; HEROIN DEPENDENCE; HUMAN; MEDICAL ETHICS; MORBIDITY; MORTALITY; NORWAY; OPIATE ADDICTION; OPIATE SUBSTITUTION TREATMENT; OUTPATIENT CARE; PATIENT CARE; RELAPSE; RISK FACTOR;

EID: 84910126625     PISSN: 15921638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Clausen T, Anchersen K, Waal H. (2008): Mortality prior to, during and after opioid maintenance treatment (OMT): a national prospective cross-registry study. Drug Alcohol Depend. 94(1-3): 151-7.
2. Gjersing, Clausen, Communication, Global Adddiction & Europad Joint Conference, Pisa, Italy, May 2013.
3. Haraldsen M. (2010): Why there has been an excess of overdoses in Norway since 1990? Heroin Addict Relat Probl 12(1): 37-40.
4. Jens Guslund, Division of drug abuse, Health Directorate, Communication at 10th International Symposium on Substance Abuse Treatment, 1-3 Oct. 2007, Oslo. http://www. tc-of. org. uk/radiotc/ch3/s14/p3s14-0004. html.
5. Kornor H, Waal H, Sandvik L (2007): Time-limited buprenorphine replacement therapy, Drug Alcohol Rev 26(2): 135-41.
6. Krook A. L., Brors O., Dahlberg J., Grouff K., Magnus P., Roysamb E., Waal H (2002): Placebo-controlled study of high dose buprenorphine in opiate dependents waiting for medication assisted rehabilitation in Oslo, Addiction 97: 5: 533-542.